
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Intervention to prevent reading problems needs to occur long before first grade. Incorporating a reading promotion program into your practice can improve the reading ability of children and bestow lifelong benefits.






